Bayot, Baby Girl .
HRN: 23-24-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/04/2023
07/11/2023
IV
45 Mg
Once Daily
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes